Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2026	Sep. 30, 2025
Current Assets
Cash and cash equivalents	$ 35,186	$ 1,309
Restricted cash	1,500
Short-term investments	7,502
Accounts receivable, net	3,629	3,945
Inventories, net	2,611	2,078
Notes receivable	4,940
Digital assets	2,120
Investment in equity securities	5,500
Prepaid expenses and other current assets	2,254	794
Total Current Assets	65,242	8,126
Fixed assets, net	9	88
Intangible assets, net	79,981
Right-of-use assets, operating leases		20
Other assets	125	168
Total Assets	145,357	8,402
Current Liabilities
Accounts payable	1,277	2,147
Accrued liabilities	1,091	1,375
Operating lease liability, short-term		21
Total Current Liabilities	2,368	3,543
Convertible debt, long-term		4,452
Total Liabilities	2,368	7,995
Stockholders’ Equity
Common Stock, $0.001 par value, 5,000,000,000 shares authorized, 19,517,637 & 416,542 shares issued and outstanding as of June 30, 2026, and September 30, 2025, respectively	1,174	31
Preferred Stock, $0.001 par value, 4,000,000 shares authorized, 5,660 & zero shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively
Additional paid-in capital, common stock	180,717	23,304
Additional paid-in capital, preferred stock	3,161
Accumulated deficit	(42,063)	(22,928)
Total Stockholders’ Equity	142,989	407
Total Liabilities and Stockholders’ Equity	$ 145,357	$ 8,402

Investment in equity securities.

No definition available.

Name:	SRXH_InvestmentInEquitySecurities
Namespace Prefix:	SRXH_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).